Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Cash from Investing Activities (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Cash from Investing Activities for 5 consecutive years, with $29.5 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 12.92% to $29.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$301.0 million through Dec 2025, down 16.65% year-over-year, with the annual reading at -$301.0 million for FY2025, 16.65% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $29.5 million at Janux Therapeutics, up from $8.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $33.9 million in Q4 2024, with the low at -$340.4 million in Q1 2025.
  • Average Cash from Investing Activities over 5 years is -$44.1 million, with a median of $4.4 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 20405.88% in 2022, then tumbled 1201.33% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $7.3 million in 2021, then plummeted by 121.89% to -$1.6 million in 2022, then surged by 793.45% to $11.1 million in 2023, then soared by 205.01% to $33.9 million in 2024, then fell by 12.92% to $29.5 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $29.5 million, $8.3 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.